Klinik protokol Az ərbaycan Respublikas

Yüklə 0,77 Mb.

Pdf görüntüsü

səhifə	26/28
tarix	19.11.2017
ölçüsü	0,77 Mb.
	#11166

1 ... 20 21 22 23 24 25 26 27 28

67. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova

R., Zampelas A. European guidelines on cardiovascular disease

prevention in clinical practice: full text. Fourth Joint Task Force of the

European Society of Cardiology and other societies on cardiovascular

disease prevention in clinical practice (consti-tuted by representatives

of nine societies and by invited experts). Eur J Cardiovasc Prev

Rehabil. - 2007. 14 Suppl 2: S1-113.

68. Gurbel PA, Bliden KP, Butler K, Tantry US, et al. Randomized double-

blind assessment of the ONSET and OFFSET of the antiplatelet effects

of ticagrelor versus clopidogrel in patients with stable coronary artery

disease: the ONSET/OFFSET study. Circulation. - 2009. - 120:2577-

2585.

69. Hiatt W.R. Medical treatment of peripheral arterial disease and

claudication. N Engl J Med. - 2001. 344:1608-1621.

70. Hippisley-Cox J, Pringle M, Hammersley V, Crown N, Wynn A, Meal

A, Coupland C. Antidepressants as risk factor for ischaemic heart

disease: case–control study in primary care. BMJ. - 2001. 323:666-669.

71. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The

Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom

Tolerance Questionnaire. Br J Addict. - 1991. 86:1119-1127.

72. He F.J., MacGregor G.A. Effect of modest salt reduction on blood

pressure: a meta-analysis of randomized trials. Implications for public

health. J Hum Hypertens. - 2002. 16:f1-770.

73. He FJ, MacGregor GA. Fortnightly review: beneficial effects of

potassium. BMJ. - 2001. 323:497-501.

74. He F.J., Nowson C.A., MacGregor G.A. Fruit and vegetable

consumption and stroke: meta-analysis of cohort studies. Lancet. -

2006. 367:320-326.

75. Heidenreich PA., Trogdon J.G., Khavjou O.A., Butler J., Dracup K.,

Ezekowitz M.D., Finkelstein E.A., Hong Y., Johnston S.C., Khera A., et

al. Forecasting the future of cardiovascular disease in the United States:

a policy statement from the American Heart Association. Circulation. -

2011. 123:933-944.

76. He J., Vupputuri S., Allen K., Prerost M.R., Hughes J., Whelton P.K.

Passive smoking and the risk of coronary heart disease - a meta-

analysis of epidemiologic studies. N Engl, J Med. - 1999. 340:920-926.

77. He K., Song Y., Daviglus M.L., Liu K., Van Horn L., Dyer A.R.,

Greenland P. Accumulated evidence on fish consumption and coronary

heart disease mortality: a meta-analysis of cohort studies. Circulation. -

2004. 109:2705-2711.

Klinik protokol Az

ərbaycan Respublikas

ı S

əhiyy

ə Nazirliyinin

İctimai S

əhi

ə v

İslahatlar M

ərk

əzind

ə haz

ırlanm

ış

dı

78. He K., Song Y., Daviglus M.L., Liu K., Van Horn L., Dyer A.R.,

Goldbourt U., Greenland P. Fish consumption and incidence of stroke:

a meta-analysis of cohort studies. Stroke. - 2004. 35:1538-1542.

79. International Agency for Research on Cancer. Tobacco Control:

Reversal of Risk After Quitting Smoking. IARC Handbooks of Cancer

Prevention, Vol. 11. Lyon: IARC. - 2007.

80. Investigators TCT. Effects of clopidogrel in addition to aspirin in

patients with acute coronary syndromes without ST-segment elevation.

N Engl J Med. - 2001. - 345:494-502.

81. Jardine M.J., Ninomiya T., Perkovic V., Cass A., Turnbull F., Gallagher

M.P., Zoungas S., Lambers Heerspink H.J., Chalmers J., Zanchetti A.

Aspirin is beneficial in hypertensive patients with chronic kidney

disease: a post-hoc subgroup analysis of a randomized controlled trial. J

Am Coll Cardiol. - 2010. 56:956-965.

82. Jamerson K., Weber M.A., Bakris G.L., Dahlof B., Pitt B., Shi V.,

Hester A., et al. Benazepril plus amlodipine or hydrochlorothiazide for

hypertension in high-risk patients. N Engl J Med. - 2008. 359:2417-

2428.

83. Jensen J, Blankenhorn DH, KornerupV. Coronary disease in familial

hypercholesterolemia. Circulation. - 1967. - 36:77-82.

84. Jousilahti P., Vartiainen E., Tuomilehto J., Puska P. Sex, age,

cardiovascular risk factors, and coronary heart disease: a prospective

follow-up study of 14 786 middle-aged men and women in Finland.

Circulation. - 1999. 99:1165-1172.

85. Katon W.J., Lin E.H., Von Korff M., Ciechanowski P., Ludman E.J.,

Young B., Peterson D., Rutter C.M., McGregor M., McCulloch D.

Collaborative care for patients with depression and chronic illnesses. N

Engl J Med. - 2010. 363:2611-2620.

86. Kaptoge S., White I.R., Thompson S.G., Wood A.M., et al. Associations

of plasma fibrinogen levels with established cardiovascular disease risk

factors, inflammatory markers, and other characteristics: individual

participant meta-analysis of 154,211 adults in 31 prospective studies:

the fibrinogen studies collaboration. Am J Epidemiol. - 2007. 166:867-

879.

87. Kodama S., Saito K., Tanaka S., Maki M., Yachi Y., Asumi M., et al.

Cardiorespiratory fitness as a quantitative predictor of all-cause

mortality and cardiovascular events in healthy men and women: a

meta-analysis. JAMA. - 2009. 301:2024-2035.

88. Lancaster T., Stead L. Physician advice for smoking cessation.

Cochrane Database Syst Rev. - 2004. 4: CD000165.